Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevention of Developmental Delays in a Down Syndrome Mouse Model

1 Dec 2008

Abstract excerpt

OBJECTIVE: To estimate whether prenatal treatment with neuroprotective peptides prevents the developmental delay and the glial deficit in the Ts65Dn mouse model for Down syndrome and to explore the peptides' effects on achievement of normal development. METHODS: Pregnant Ts65Dn females were randomly assigned to NAPVSIPQ+SALLRSIPA or control and were treated by investigators blinded to treatment and genotype on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cerebral Palsy and Movement Disorders
Share to Down syndrome and intellectual disability research
Share to Infant Development and Preterm Care

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19037032
DOI: 10.1097/aog.0b013e31818c91dc

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevention of Developmental Delays in a Down Syndrome Mouse ModelPMID 19037032Read ↗

Defects in Embryonic Neurogenesis and Initial Synapse Formation in the Forebrain of the Ts65Dn Mouse Model of Down SyndromeSemantic proximity Read ↗

Is it possible to improve neurodevelopmental abnormalities in Down syndrome?Semantic proximity Read ↗

Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome miceSemantic proximity Read ↗

The fetal brain transcriptome and neonatal behavioral phenotype in the Ts1Cje mouse model of Down syndrome.Semantic proximity Read ↗

Embryonic and not maternal trisomy causes developmental attenuation in the Ts65Dn mouse model for Down syndrome.Semantic proximity Read ↗

Long‐term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer's diseaseSemantic proximity Read ↗

Abnormal expression of synaptic proteins and neurotrophin-3 in the down syndrome mouse model Ts65DnSemantic proximity Read ↗

Sex-specific developmental phenotypes and their response to neonatal <i>Dyrk1a</i> reduction in the Ts65Dn Down syndrome mouse modelSemantic proximity Read ↗

Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerationsSemantic proximity Read ↗

Prenatal pharmacotherapy rescues brain development in a Down’s syndrome mouse modelSemantic proximity Read ↗

New Perspectives for the Rescue of Cognitive Disability in Down SyndromeSemantic proximity Read ↗

Challenges and Opportunities for Translation of Therapies to Improve Cognition in Down Syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.